HOOK Company Profile and Key Details

Q: Who are the executives of HOOK?

Mr. Andreas BergthalerCo-FounderMr. Jorn AldagChief Executive Officer & DirectorMr. Joern AldagChief Executive Officer & DirectorProf. Rolf M. Zinkernagel M.D., Ph.D.Co-FounderDr. Roman Necina Ph.D.Chief Devel. OfficerDr. Reinhard Kandera Ph.D.Chief Financial Officer & DirectorMr. Michael SzumeraExecutive Director of CommunicationsMs. Christine D. Baker M.B.A.Chief Operating OfficerMs. Marine PopoffCommunications & Investor Relations Mang.Dr. Klaus Orlinger Ph.D.Chief Scientific OfficerMr. Lukas FlatzCo-FounderMr. Matthew L. S. BeckExecutive Director of Investor Relations

NASDAQ : HOOK

HOOKIPA Pharma

$1.02

-0.01-0.97%

At Close 4:00 PM

70.51

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

HOOKIPA Pharma Inc. (HOOK) stock declined over -0.97%, trading at $1.02 on OTC, down from the previous close of $1.03. The stock opened at $1.00, fluctuating between $1.00 and $1.02 in the recent session.

Stock Snapshot

1.03

Prev. Close

12.77M

Market Cap

Day Low

-0.21

P/E Ratio

-4.83

EPS (TTM)

-0.62

Cash Flow per Share

Open

12.52M

Number of Shares

1.02

Day High

79.14%

Free Float in %

0.91

Book Value

206

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Mar 02, 2026	1.00	1.02	1.00	1.02	1.88K
Feb 27, 2026	1.03	1.03	1.02	1.03	2.57K
Feb 26, 2026	1.01	1.05	1.01	1.04	12.06K
Feb 25, 2026	1.02	1.05	1.02	1.05	2.62K
Feb 24, 2026	1.01	1.01	1.01	1.01	526
Feb 23, 2026	1.01	1.04	1.01	1.01	6.46K
Feb 20, 2026	1.03	1.03	1.01	1.01	3.64K
Feb 19, 2026	1.02	1.04	1.02	1.04	5.24K
Feb 18, 2026	0.99	1.05	0.99	1.05	418
Feb 17, 2026	0.99	1.04	0.99	1.04	4.68K
Feb 13, 2026	1.01	1.02	0.99	1.00	1.5K
Feb 12, 2026	1.03	1.03	1.02	1.03	2.48K
Feb 11, 2026	1.02	1.03	1.02	1.02	3.29K
Feb 10, 2026	1.02	1.08	1.02	1.06	21.16K
Feb 09, 2026	1.02	1.06	1.02	1.02	4.51K
Feb 06, 2026	1.05	1.05	1.01	1.05	5.15K
Feb 05, 2026	1.00	1.06	0.99	1.01	2.28K
Feb 04, 2026	1.01	1.07	1.01	1.05	13.25K
Feb 03, 2026	1.00	1.08	1.00	1.04	29.05K
Feb 02, 2026	0.99	1.00	0.98	1.00	23.25K

Contact Details

New York City, NY 10118

United States

https://www.hookipapharma.com 431 890 6360

About Company

HOOKIPA Pharma Inc., a clinical stage biopharmaceutical company, develops immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform. The company's lead infectious disease product candidate is HB-101, which is in a randomized double-blinded Phase II clinical trial in patients awaiting kidney transplantation from cytomegalovirus-positive donors. Its lead oncology product candidates are HB-201 and HB-202 that are in Phase I/II clinical trial for the treatment of human papillomavirus 16-positive cancers. The company's preclinical stage products include HB-300 program for prostate cancer; and HB-700 for targeting mutated KRAS in pancreatic, colorectal, and lung cancer. HOOKIPA Pharma Inc. has a collaboration with Gilead Sciences, Inc. to collaborate on preclinical research programs to evaluate potential vaccine products using or incorporating its replicating and non-replicating technology platforms for the treatment, cure, diagnosis, or prevention of Hepatitis B Virus. The company was incorporated in 2011 and is headquartered in New York, New York.

Stock Peers

ODTC

Odonate Therapeutics, Inc.$2,849.50 GNMSF

Genmab A/S$268.61 CMXHF

CSL Limited$192.00 NONOF

Novo Nordisk A/S$144.95 CSLLY

0.75+0.79%

CSL Limited$95.35 UCBJY

-0.06-0.08%

UCB SA$73.15 PHMMF

4.3+16.01%

Pharma Mar, S.A.$31.15 BVNKF

Bavarian Nordic A/S$21.20 NURPF

Neuren Pharmaceuticals Limited$14.00 FNCH

-0.05-0.38%

Finch Therapeutics Group, Inc.$13.20

Frequently Asked Questions

What is the current HOOKIPA Pharma Inc. (HOOK) stock price?

HOOKIPA Pharma Inc. (OTC: HOOK) stock price is $1.02 in the last trading session. During the trading session, HOOK stock reached the peak price of $1.02 while $1.00 was the lowest point it dropped to. The percentage change in HOOK stock occurred in the recent session was -0.97% while the dollar amount for the price change in HOOK stock was - $0.01.

HOOK's industry and sector of operation?

The OTC listed HOOK is part of Biotechnology industry that operates in the broader Healthcare sector. HOOKIPA Pharma Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of HOOK?

Mr. Andreas Bergthaler
Co-Founder
Mr. Jorn Aldag
Chief Executive Officer & Director
Mr. Joern Aldag
Chief Executive Officer & Director
Prof. Rolf M. Zinkernagel M.D., Ph.D.
Co-Founder
Dr. Roman Necina Ph.D.
Chief Devel. Officer
Dr. Reinhard Kandera Ph.D.
Chief Financial Officer & Director
Mr. Michael Szumera
Executive Director of Communications
Ms. Christine D. Baker M.B.A.
Chief Operating Officer
Ms. Marine Popoff
Communications & Investor Relations Mang.
Dr. Klaus Orlinger Ph.D.
Chief Scientific Officer
Mr. Lukas Flatz
Co-Founder
Mr. Matthew L. S. Beck
Executive Director of Investor Relations

How HOOK did perform over past 52-week?

HOOK's closing price is 41.47% higher than its 52-week low of $0.72 where as its distance from 52-week high of $1.77 is -42.37%.

How many employees does HOOK have?

Number of HOOK employees currently stands at 82.

Link for HOOK official website?

Official Website of HOOK is: https://www.hookipapharma.com

How do I contact HOOK?

HOOK could be contacted at phone 431 890 6360 and can also be accessed through its website. HOOK operates from 350 Fifth Avenue, New York City, NY 10118, United States.

How many shares of HOOK are traded daily?

HOOK stock volume for the day was 206 shares. The average number of HOOK shares traded daily for last 3 months was 11K.

What is the market cap of HOOK currently?

The market value of HOOK currently stands at $12.77M with its latest stock price at $1.02 and 12.52M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	82
Beta	0.89
Sales or Revenue	$20.13M
5Y Sales Change%	-0.974%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

Employees	82
Beta	0.89
Sales or Revenue	$20.13M
5Y Sales Change%	-0.974%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

HOOK Company Profile and Key Details

HOOKIPA Pharma

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Earnings & Analyst Outlook

Dividend & Fair Value

Company Overview

Price Forecast & Outlook

Key Takeaways

Valuation Metrics